Global Cord Blood Corporation (NYSE:CO) is reporting second quarter financial results on Tuesday 24th November 2020, after market close.
Previous Quarter Performance
Global Cord Blood Corporation revealed income for the first quarter of $ 0.15 per share, from the revenue of $ 39.76 million.
Stock Performance
Shares of Global Cord Blood Corporation traded up $ 0.10 or 2.45 percent on Monday, reaching $ 4.19 with volume of 103.50 thousand shares. Global Cord Blood Corporation has traded high as $ 4.25 and has cracked $ 4.11 on the downward trend
According to the previous trading day, closing price of $ 4.19, representing a 61.02 % increase from the 52 week low of $ 2.54 and a 22.1 % decrease over the 52 week high of $ 5.25.
The company has a market capital of $ 509.30 million and is part of the Healthcare sector and Biotechnology industry.
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the Peoples Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province.
